Ticker LaunchLondon · AIM · IPO · GENI
GENinCode plc
GENinCode plc (GENI) was admitted to AIM on Jul 22, 2021, raising £17M at 44p per share. Its market capitalization at admission was about £42.2M. Stifel Nicolaus Europe Limited acted as nominated adviser, with Stifel Nicolaus Europe Limited (nominated adviser, sole global coordinator, joint bookrunner, joint broker) and Cenkos Securities plc (joint bookrunner, joint broker) as broker.
GENinCode is a cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- GENI
- Admitted
- Jul 22, 2021
- Offer price
- 44p
- Raised
- £17M
- Market cap at admission
- £42.2M
- Nominated adviser
- Stifel Nicolaus Europe Limited
- Brokers
- Stifel Nicolaus Europe Limited (nominated adviser, sole global coordinator, joint bookrunner, joint broker) and Cenkos Securities plc (joint bookrunner, joint broker)
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Microlise Group PlcAIM · Jul 22, 2021
- Zenova Group PlcAIM · Jul 22, 2021
- Lords Group Trading PlcAIM · Jul 20, 2021
- Revolution Beauty Group plcAIM · Jul 19, 2021
- Sivota PlcMain Market · Jul 19, 2021
- Forward Partners Group PlcAIM · Jul 19, 2021